DNA Cytometry Testing for Cervical Cancer Screening – Response
نویسندگان
چکیده
We appreciate the interest of Drs. Garner, Guillaud, and MacAulay in our work and thank them for their critical comments on our recent publication (1). Early detection of cancerous lesions is a pivotal step for reducing cervical cancer–associated mortality. Finding a method which possesses high sensitivity and specificity in screening of mass populations has been difficult for cancer researchers. False negatives are a major problem for cervical cancer testing using conventional cytologic methods and frequent retesting is required (2). Previous studies have reported that DNA ploidy testing could increase the positive prediction of precancerous and cancerous lesions of uterine cervix compared with cytology (3–5). However, there has been little data on DNA ploidy cytometry testing as a single detection method in low-resource countries where it might be used for large population screening. This was the basis for performing the randomized study under discussion. Our goal was to test the hypothesis that DNA ploidy cytometry testing would be superior to conventional cytologic screening to detect early precancerous or cancerous cervical lesions. First, we need to clarify the design of our study as to whether it was a randomized controlled trial or not. Garner et al. critically said that our study was not a randomized trial because the data analyzed in our study were pooled together from both arms. In fact, we did perform both DNA cytometry and the cytologic evaluation on all patients' specimens. This was done for ethical reasons because performing a single test on each arm would not have been approved by our institutional review boards. In Table 2 from our article, the results we reported included crossover screening. We apologize for not making this clear. However, all study processes were conducted in a randomized manner, i.e., patient's eligibility screening, randomization, blindness concealment and uncovering, intention-to-treat, and per protocol analyses. Such analyses, at first, gave an overall understanding as to the two
منابع مشابه
Pnm-17: Cost Effectiveness of Human Papillomavirus Testing in Cervical Cancer Diagnosis
Background: Epidemiological studies are shown robust association between human papillomavirus (HPV) and cervical cancer. From 1990 HPV was known as a necessary but insufficient cause of cervical invasive cancer. The purpose of this study was to evaluate the cost effectiveness of HPV test in cervical cancer screening. Materials and Methods: This is a systematic review article; the newest scienti...
متن کاملImaging, Diagnosis, Prognosis DNAPloidy Cytometry Testing for Cervical Cancer Screening in China (DNACIC Trial): a Prospective Randomized, Controlled Trial
Purpose: This randomized, controlled trial was designed to determine whether the DNA cytometry testing is superior to the conventional cytologic testing for mass cervical cancer screening. Experimental Design: After approval by the institutional ethics review boards from three separate screening centers, a total of 23,993 Chinese women ages 20 to 65 years were randomly assigned into one of the ...
متن کاملAuthor's response to reviews Title: Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip HPV assays Authors:
High-risk types of human papillomavirus (HPV) are the causative agents of cervical cancer. Cervical screening could be improved by testing for the DNA of high-risk types of HPV as a primary screening tool. Authors: Cervical cancer is caused by high-risk types of human papillomavirus (HPV). DNA testing of such high-risk types of HPV could improve cervical screening. Background: High-risk types o...
متن کاملComparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
Cervical cancer is a serious disease that threatens the health of women worldwide. This study compared the sensitivities and false-positive rates of cervical cytology (Pap smear), human papilloma virus (HPV) DNA test, cervicography, first double-combined testing (cervical cytology and HPV DNA test), second double-combined testing (cervical cytology and cervicography) and triple-combined testing...
متن کاملAnatomic Pathology / DNA PLOIDY IN NORMAL SMEARS WITH HIGH-RISK HUMAN PAPILLOMAVIRUS
To improve the positive predictive value (PPV) for high-risk human papillomavirus (HR-HPV) in primary screening, DNA ploidy was measured on the same liquid-based sample by image cytometry in 984 cases showing discrepancies between cytology and HR-HPV testing. Of the conflicting results, 14.5% corresponded to a cytologic lesion (from atypical squamous cells of undetermined significance to high-g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010